Austin, Texas, August 10th, 2026, FinanceWire

This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising. Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) announced that the U.S. Food and Drug Administration has approved its Investigational New Drug (“IND”) application for Lucid-MS (Lucid-21-302), clearing the company to advance the patented, first-in-class multiple sclerosis candidate into Phase 2 clinical development. […]

Across the United States, a quiet but consequential shift is underway in how communities approach public safety. Rather than treating equipment, training and accountability as separate priorities, agencies are increasingly seeking integrated systems that connect the tools officers carry with the training that prepares them and the data that documents every encounter. This full-stack approach […]

Nicosia, Cyprus, August 10th, 2026, FinanceWire